Agoraphobia: symptoms, causes and effective treatments

Agoraphobia refers to an irrational fear of situations in which escaping or obtaining help would be difficult. It is not simply a fear of crowds: the term describes a much more specific clinical condition.

Clinical definition and classification

According to the DSM-5, the reference classification of mental disorders[1], agoraphobia is an anxiety disorder in its own right, distinct from panic disorder. Diagnosis is based on several criteria: marked fear or anxiety in at least two types of situations (public transport, open spaces, enclosed spaces, queues or crowds, being alone outside the home), an anxious response to these situations almost every time, active avoidance, and a minimum duration of 6 months. The disorder most often begins in adolescence or early adulthood. It affects approximately 1 to 2% of the population in a given year, more often women[1]. The disorder persistently disrupts daily life and causes significant distress, which distinguishes it from temporary apprehension.

Etymology and clarification of the term

The word comes from the Greek agorá (public square) and phóbos (fear). The German psychiatrist Carl Westphal coined the term in 1871, in an article entitled Die Agoraphobie, after observing patients who were unable to cross Berlin's large squares. The etymology points towards open spaces, but the current clinical definition is broader: what is feared is the inability to escape or receive help, whether the place is a crowded square, a supermarket or public transport. Fear of crowds is therefore only one facet of the disorder, not its complete definition.

Agoraphobia manifests itself in three distinct domains: physical, psychological and behavioural. Each reinforces the others in a self-perpetuating cycle.

Physical symptoms

Bodily manifestations occur before or during exposure to feared situations. They are often intense and can be mistaken for a medical emergency. The main physical symptoms are:

• Palpitations and an increased heart rate
• Trembling of the hands or the whole body
• Cold sweats or hot flushes
• Dizziness and feelings of unsteadiness
• Nausea or abdominal discomfort
• A choking sensation or shortness of breath
• Chest pain or tightness in the chest
• Shaky legs, feeling unable to remain standing

These bodily sensations directly fuel fear: the person interprets these signals as evidence of real danger, which amplifies anxiety.

Psychological and cognitive symptoms

Beyond the body, agoraphobia draws on considerable mental resources. The most common psychological manifestations are:

• Fear of dying or experiencing a serious medical episode
• Fear of losing control of oneself or one's actions
• Fear of going mad or descending into madness
• A sense of unreality (depersonalisation, derealisation)
• Constant anticipatory anxiety, long before exposure to the situation
• Persistent hypervigilance towards bodily and environmental signals

This anticipatory anxiety is particularly disabling: distress often begins long before entering the feared situation.

Avoidance and restriction of activities

Avoidance is the direct behavioural consequence of these symptoms. The person gradually organises their life around avoiding anxiety-provoking situations: they avoid public places, transport, crowds, open spaces or, conversely, places that would be difficult to leave.

One common mechanism is the need for a trusted person to go out. Alone, the person cannot manage it. With someone accompanying them, they tolerate the situation better. This need for a companion itself becomes an additional constraint.

Over time, the number of accessible places decreases. The person's living radius shrinks. Some people eventually stop leaving their home, leading to severe social and occupational isolation. Restricting activities is not a choice: it is a survival strategy in the face of anxiety that has become unbearable.

The link between agoraphobia and panic disorder is central, but often misunderstood. The two disorders can coexist or occur separately.

A panic attack (or an episode of acute anxiety) is characterised by a sudden surge of intense symptoms: palpitations, a choking sensation, fear of dying, trembling. The attack peaks within a few minutes and generally subsides in less than 30 minutes. It is often unpredictable, which makes it particularly unsettling.

When these attacks recur, the person develops a fear of fear: they constantly anticipate the next attack. This mechanism, described by Ameli.fr as anticipatory fear[2], drives avoidance of situations associated with past attacks. Agoraphobia then becomes established as a strategy for avoiding settings in which another panic attack might occur.

Good to know: Since the DSM-5, agoraphobia and panic disorder have been two distinct diagnoses, which can be made together or separately. Between 30 and 50% of people with agoraphobia also have panic disorder[1]. In these cases, the attacks are often the main driver of avoidance. Without panic disorder, the fear of being unable to escape or obtain help exists independently of any panic attack. This distinction is crucial in guiding treatment: care focused on panic disorder will not be sufficient if agoraphobia has developed its own dynamic.

In all cases, avoidance reinforces the disorder. Each avoided situation confirms, in the person's eyes, that the place was indeed dangerous.

No single cause explains agoraphobia. The disorder results from an interaction between several biological, psychological and environmental factors, whose relative influence varies from person to person.

The factors identified by research and listed by Ameli.fr[2] include:

• Family history of anxiety disorders: genetic vulnerability may predispose someone to developing pathological anxiety
• Traumatic events: a frightening experience in a public place, a panic attack in a particular context, or a period of intense stress may trigger the disorder
• Anxious personality: some people, who are naturally more sensitive to signs of danger, develop avoidance behaviours more readily
• Alcohol or drug use: these substances may trigger or worsen episodes of anxiety, creating conditions conducive to the development of agoraphobia
• Other medical or psychiatric conditions: depression, other phobias or a pre-existing anxiety disorder may contribute to the onset of the disorder

In some people, agoraphobia develops gradually without an identifiable triggering event. The absence of a definite cause does not compromise therapeutic care.

Both disorders belong to the family of anxiety disorders and can coexist in the same person. However, their central mechanisms differ.

Agoraphobia is based on the fear of being unable to escape or obtain help in certain situations. The presence of other people is not the problem in itself: it is the inability to escape that generates anxiety. A person with agoraphobia may fear a crowd as much as a deserted open space.

Social phobia (or social anxiety disorder) centres on other people's scrutiny and judgement. The person fears acting in an embarrassing way, being humiliated or being negatively evaluated. It is the presence of others that triggers anxiety, not the layout of the place.

In practice:

• Agoraphobia: fear of places from which escape would be difficult, regardless of other people's scrutiny
• Social phobia: fear of judgement and humiliation in social interactions
• The two disorders can overlap, which complicates diagnosis and requires assessment by a mental health professional

The distinction matters because treatment protocols, although similar in their use of exposure, target different mechanisms.

Establishing the diagnosis

The diagnosis of agoraphobia is based on DSM-5 criteria: marked fear or anxiety in at least two types of situations, an anxiety response almost every time, active avoidance, a duration of at least 6 months, and a significant impact on daily life. Only a mental health professional (psychologist, psychiatrist) can make this diagnosis, after ruling out other anxiety disorders or medical causes. Standardised assessment scales may complement the clinical interview.

Available treatments

Several approaches have demonstrated their effectiveness. They may be combined depending on the severity of the disorder and the patient's profile.

Cognitive behavioural therapy (CBT)

Cognitive behavioural therapy is the first-line treatment for agoraphobia. A Cochrane meta-analysis of 60 randomised trials ranks it ahead of other psychotherapies in most comparisons, with modest differences and a low level of evidence[3]. It is based on two complementary components: cognitive restructuring (identifying and challenging the irrational thoughts that fuel fear) and graded exposure (gradually re-engaging with avoided situations).

The aim is not to eliminate all anxiety, but to learn to remain in the situation without consistently responding by escaping. Each successful experience gradually recalibrates the perception of danger.

Some practitioners incorporate therapeutic virtual reality to facilitate this graded exposure in a controlled, reproducible setting, adapting the intensity of the situations to the patient's reactions.

Gradual exposure in virtual reality

Virtual reality exposure therapy (VRET) is a complementary tool to conventional CBT, particularly suited to agoraphobia. Its effectiveness is documented: in a randomised trial conducted by Pelissolo et al. involving 92 patients, virtual reality exposure and conventional CBT showed no difference in effectiveness after 12 weeks[4]. A meta-analysis also found no difference compared with exposure in real-life situations, based on a still limited number of trials[5]. The environments are controlled, reproducible and free from external constraints. The practitioner controls exposure in real time and adjusts the parameters according to the patient's reactions.

C2Care offers more than 250 exposure situations that can be controlled from a single platform, with real-time parameter adjustments according to each patient's goals and pace. To date, C2Care has 700 trained practitioners and a presence in 25 countries. To learn more about this method, visit the page dedicated to virtual reality exposure therapies.

Medication

SSRI antidepressants (selective serotonin reuptake inhibitors) may be prescribed alongside psychotherapy, particularly in severe cases[1]. Medication alone is not sufficient: it is always combined with therapeutic support. Any decision about medication must be made by a healthcare professional.

Agoraphobia is a common anxiety disorder, with physical and psychological symptoms that are often disabling. Its link with panic disorder is real, but the two disorders can exist separately. CBT with gradual exposure remains the first-line treatment, supplemented by medication if needed. Consulting a mental health professional remains the first step. With appropriate support, returning to normal daily life is an achievable goal.